Schlagwort: Biotech companies
The Biotech IP Flip: Scaling Up Instead of Selling
Many European biotech companies still view the U.S. market primarily as a future exit channel. Yet it can be leveraged much earlier - not...
Comparing late-stage vs. early-stage investment strategies
It is generally believed that, as projects advance in discovery research, little value is created because the products are still years away from the...